c‐Myc deregulation is a common feature of most human cancers.[24, 25] Western blotting results showed that RTN4IP1 expression was consistent with that of c‐Myc in cells treated with BRD4 inhibitors (Figure S1H, Supporting Information). The gene discussed is MYC; the disease is cancer.